Munich, Germany

Andrea Aschenbrenner



Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • München, DE (2005)
  • Munich, DE (2012)

Company Filing History:


Years Active: 2005-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Andrea Aschenbrenner

Introduction

Andrea Aschenbrenner is an accomplished inventor based in Munich, Germany. With a focus on innovative pharmaceuticals, she holds two patents that showcase her expertise in the field of medicinal chemistry and drug development.

Latest Patents

Andrea's latest patents include significant advancements in the realm of aryloxypropanolamines. The first patent concerns novel aryloxypropanolamines, detailing methods for their preparation and use as medicaments. These compounds exhibit agonistic activity at β3 adrenergic receptors, making them valuable for treating conditions influenced by the activation of these receptors. Moreover, Andrea has developed compounds for the treatment of protozoal diseases, introducing a new diphenylurea formula or its salt that holds promise in combating these health issues.

Career Highlights

Throughout her career at 4SC AG, Andrea has demonstrated an unwavering commitment to research and innovation. Her work exemplifies a blend of scientific rigor and creative problem-solving, contributing to the advancement of medical therapies.

Collaborations

In her pursuit of innovation, Andrea collaborates with skilled colleagues, including Kristina Wolf and Stefan Tasler. Together, they foster a dynamic research environment that encourages the exploration of new ideas and the development of effective pharmaceutical solutions.

Conclusion

Andrea Aschenbrenner’s contributions to the field of medicinal chemistry underscore her role as a pioneering inventor. With her groundbreaking patents and collaborative spirit, she is well-positioned to continue making significant impacts in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…